SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Servier at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
Servier brings 4 presentations to SNO 2026 in Philadelphia. Its program centres on vorasidenib for IDH-mutant glioma, with updated INDIGO trial results and real-world adherence data. Its industry-supported sessions cover IDH-mutant glioma care.
| Organization | SNO 2026 Attendance |
|---|---|
Servier Suresnes, France | ◆Platinum Supporter |
An international pharmaceutical company developing and marketing medicines, including cancer therapies. | Talk Fri Nov 13 7–8:15am Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 7–8:15am Talk Sat Nov 14 10:15–11:15am |
Find decision makers at Servier
Tell us what you sell and we’ll find the people at Servier most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction